Monday, August 21st
MMCRI’s Responsible Conduct of Research Program: “Emerging ethical issues in CRISPR Genome Editing”
When: 10 a.m. – noon
Where: MMCRI Conference Room 1, 81 Research Drive, Scarborough, Maine 04074
All are welcome!
Monday, August 28th
“Gene Enhancement and Gene Doping: The Next Big Threat to the Spirit of Sport?”
When: 5:30-6:30 PM,
Where: Dana Center Room #7, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102.
All are welcome!
Contact for these two seminars:
Leisa Collins, M.Ed., Program Coordinator, Center for Molecular Medicine, Maine Medical Center Research Institute
Co-authored with Mike Mcnamee
The focus of this chapter is on the Philosophy of Sports Medicine, that is, the practice of medicine in the context of sport. The chapter begins by examining ways in which a distinction in kind can be claimed between Sports Medicine and Medicine per se. It does this by focussing first on the goals of medicine. This strategy proves to be indecisive, and it is concluded that a difference in degree only, rather than in kind, can be claimed for Sports Medicine. However, when the focus is directed to the normative aspects of Medicine per se, in comparison with Sports Medicine, important differences can be identified. These differences concern, especially, the way in which normative concepts central to medicine per se are operationalized in Sports Medicine. It is shown how norms regarding privacy, confidentiality, autonomy, and paternalism all apply in significantly different ways in the sporting context. Parallel differences are also identified in relation to the therapy/enhancement distinction. The problem of balancing current sporting goals against long-term health is also discussed.
You can access the Handbook’s table of content here:
If you would like a copy of the chapter please drop me an email.
In my role as Associate Editor for Reproductive Ethics, I recently wrote this editorial for the Journal of Bioethical Inquiry. Here’s an excerpt from that article:
‘Human reproduction is increasingly being externalized. We have a number of technologies that make this possible: in vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), gamete donation, surrogacy, and, more recently, mitochondrial transfer technologies and uterus transplant. [..]
This Bioethics and Biopolitics: Presents and Futures of Reproduction symposium draws together a series of articles that were each submitted independently by their authors to the JBI and which explore the biopower axis in the externalization of reproduction in four contexts: artificial gestation (ectogenesis), PGD for sex selection, women’s (reproductive) rights, and testicular cryopreservation (TCCP). While one contribution explores a “future” of reproduction, the other three explore a “present,” or better, explore different “presents.” What may counts as “present,” and what may count as “future,” has dramatically different connotations depending on the geographical declination of the tense’.
The full article was published on June 12th, 2017 and is available open-access here: